Table 1.
Group | FDR p value | |||
---|---|---|---|---|
MVO(−)/IMH(−) (n = 41) | MVO(+)/IMH(−) (n = 10) | MVO(+)/IMH(+) (n = 39) | ||
Age (years) | 61 ± 9 | 59 ± 15 | 59 ± 12 | 0.64 |
Male (%) | 27 (66) | 6 (60) | 32 (82) | 0.29 |
DM (%) | 4 (10) | 1 (10) | 1 (3) | 0.49 |
Smoking (%) | 33 (80) | 9 (90) | 36 (92) | 0.38 |
Hypertension (%) | 20 (49) | 3 (30) | 12 (31) | 0.35 |
Hypercholesterolaemia (%) | 11 (27) | 3 (30) | 11 (28) | 0.95 |
Positive family history (%) | 16 (39) | 3 (30) | 22 (56) | 0.29 |
Anterior location (%) | 10 (24) | 2 (20) | 16 (41) | 0.30 |
Previous angina (%) | 13 (32) | 3 (30) | 21 (54) | 0.20 |
GIIbIIIa inhibitor (%) | 17 (41) | 5 (50) | 23 (59) | 0.38 |
TIMI 3 | ||||
Pre-PCI (%) | 10 (24) | 0 (0) | 0 (0) | 0.004 |
Post-PCI (%) | 36 (88) | 9 (90) | 35 (90) | 0.66 |
Rentrop ≥2 (%) | 9 (22) | 5 (50) | 7 (18) | 0.20 |
Thrombosuction (%) | 9 (22) | 2 (20) | 11 (28) | 0.89 |
Time to PCI (min) | 217 (165–304) | 177 (148–248) | 201 (160–291) | 0.65 |
AAR (%) | 19 ± 121.2 | 27 ± 81 | 33 ± 92 | <0.001 |
IS (%) | 8 ± 83.4 | 16 ± 73.5 | 23 ± 94.5 | <0.001 |
Myocardial salvage (%) | 54 ± 326 | 40 ± 25 | 28 ± 246 | 0.004 |
MVO (% of LV mass) | 0 | 0.8 (0.4–1.9) | 1.7 (1.0–3.3) | 0.07 |
IMH (% of LV mass) | 0 | 0 | 1.6 (1.0–2.4) |
Values are presented as mean ± SD or median and IQR; AAR: area at risk; DM: diabetes mellitus; IS: infarct size at baseline; IHM: intramyocardial haemorrhage; MVO: microvascular obstruction; PCI: percutaneous coronary intervention. Superscripts indicate significant post-hoc, pairwise comparisons